FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Drug Development Tool Qualification Stats

FDA publishes six-month summary statistics for drug development tool qualification projects.

Human Drugs

FDA Wants Doctors to Discuss Naloxone with Patients

FDA says healthcare professionals should discuss naloxone with patients taking opioid pain medicines or drugs for opioid use disorder and consider pre...

Human Drugs

Fresenius Recalls 2 Lots Dexmedetomidine

Fresenius Kabi recalls two lots of dexmedetomidine HCl in 0.9% sodium chloride injection due to the possibility of a trace amount of lidocaine present...

FDA Warns Clinics on Unapproved Covid Cures

FDA and the Federal Trade Commission says Create Wellness Clinics is marketing several types of unapproved products intended to treat Covid-19.

Medical Devices

Many Recalls in Healthcare Deployment of Devices: Report

Internet of Things (IoT) security firm Ordr says many IoT medical devices have been subject to FDA recall as defective or risky.

Medical Devices

Senate Bill on FDA Seizing/Detroying Counterfeit Devices

U.S. senators Mike Enzi (R-WY) and Maggie Hassan (D-NH) introduce legislation that would help protect patients from counterfeit medical products that ...

Federal Register

More Class 2 Devices Exempt from 510(k)

Federal Register notice: FDA publishes an order to exempt a list of Class 2 devices from 510(k) requirements, subject to certain limitations.

Federal Register

Guide on Human Cell Tissue Products

Federal Register notice: FDA makes available a final guidance entitled Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Bas...

Human Drugs

Dont License Mesoblasts Ryoncil: Petition

A Lassman Law & Policy petition asks FDA to require substantial evidence of effectiveness before approving a BLA for Mesoblasts Ryoncil.

Human Drugs

Positive CDER Response to Liver Safety Biomarker

CDER accepts a C-Path qualification plan for glutamate dehydrogenase as a safety biomarker for drug-induced liver injury.